There are two major myeloid pulmonary dendritic cell (DC) populations: CD103 ؉ DCs and CD11b high DCs. In this study, we investigated in detail the origins of both myeloid DC pools using multiple experimental approaches. We show that, in resting lung, Ly-6C high CCR2 high monocytes repopulated CD103 ؉ DCs using a CCR2-dependent mechanism, and these DCs preferentially retained residual CCR2 in the lung, whereas, conversely, Ly-6C low CCR2 low monocytes repopulated CD11b high DCs. CX3CR1 was required to generate normal numbers of pulmonary CD11b high DCs, possibly because Ly-6C low monocytes in the circulation, which normally express high levels of CX3CR1, failed to express bcl-2 and may have diminished survival in the circulation in the absence of CX3CR1. Overall, these data demonstrate that the two circulating subsets of monocytes give rise to distinct tissue DC populations.
T here are two major myeloid CD11c
ϩ MHCII ϩ dendritic cell (DC) 4 populations in the airway and lung interstitium: CD11b high CD103 Ϫ and CD11b low CD103 ϩ DCs (1). CD103 is the ␣ E integrin subunit that pairs with ␤ 7 to generate a functional integrin that binds to E-cadherin (2) . In the intestine, CD103
ϩ DCs stand out among other intestinal DCs as the critical DC subset for inducing T regulatory cells (3, 4) and instructing expression of the gut-homing molecules CCR9 and ␣ 4 ␤ 7 on T cells (3) . It remains unknown whether CD103
ϩ DCs in the lung function similarly as in the intestine. Recent data indicate that CD103 ϩ lung DCs preferentially present Ag to CD8 ϩ T lymphocytes (5) . CD11b high lung DCs produce a broad spectrum of chemokines (6) and may be oriented toward perpetuation of airway effector responses and inflammation (7) , whereas CD103 ϩ lung DCs produce mainly CCL17 and CCL22 that attract Th2 and regulatory T cells (6) .
Both CD103 ϩ and CD11b high DCs in the airway and lung parenchyma emigrate to the mediastinal (bronchial) lymph nodes, even in the steady state without overt inflammation (8) . This ongoing migration out of the pulmonary space is substantial, such that the turnover time of airway DCs is brief, on the order of a few days (9 -12) . However, the precursors that serve to replenish pulmonary DCs are fully not delineated. Recent data indicate that monocytes are precursors for pulmonary DCs (13, 14) , but the various subpopulations of DCs in the lung were not specifically traced; therefore, many important questions regarding the role of monocytes as precursors for pulmonary DCs remain to be answered.
There are two main monocyte subsets in mice: CCR2 high Ly-6C high (also called Gr-1 high ) monocytes, which are the more classical monocytes that readily emigrate to sites of ongoing inflammation (15) (16) (17) (18) (19) (20) (21) (22) (23) ; and CCR2 low Ly-6C low (also called Gr-1 low ) monocytes (24, 25) , which express the highest level of CX3CR1 among circulating adult leukocytes (15) . The human counterparts of these subsets are CD14 ϩ CD16 Ϫ and CD14 low CD16 ϩ monocytes, respectively (15, 26) . Mouse monocytes that develop in the bone marrow are mainly of the Ly-6C high population (27, 28) . Ly-6C low monocytes descend from Ly-6C high monocytes (13, 16, 28) through a conversion event that is not yet well characterized, and the biology of these monocytes is generally poorly understood. Ly-6C low monocytes do not robustly emigrate to many tissues, but they do migrate well to lung even in the absence of inflammation (15) . Thus, studies of their fate after emigration into lung may be especially useful in revealing insight into their differentiation and functional properties.
In this study, we conducted experiments to evaluate the role of each monocyte subset in giving rise to CD103 ϩ or CD11b high pulmonary DCs. Our data reveal that CD103 ϩ and CD11b high DCs in the lung arise from monocytes. However, the two subsets of monocytes become different types of DCs. Ly-6C low monocytes develop into CD11b high DCs, whereas Ly-6C high monocytes become CD103 ϩ DCs. Our data thus provide the first evidence that the two subsets of monocytes recruited to the same tissue undergo differential differentiation pathways within the DC lineage. Our data also provide insight into how the frequencies of CD103 ϩ DCs vs CD11b high DCs in the lung, two populations with distinct functions in immunity, are regulated and may be manipulated.
Materials and Methods

Parabiosis
C57BL/6 mice (CD45.2 ϩ or CD45.1 ϩ ) were purchased from Jackson ImmunoResearch Laboratories or the National Cancer Institute. These mice, or in other experiments not shown C57BL/Ka and C57BL/Kaactin/eGFP mouse strains (bred and maintained at the Harvard School of Public Health (29)), were used in parabiotic studies wherein two mice are surgically joined. Parabiotic mice were sacrificed by 8 wk after surgery. The Institutional Animal Care and Use Committees at Mount Sinai School of Medicine or Harvard University approved all procedures.
LPS-treated mice
Fully anesthetized WT C57BL/6 mice were intranasally treated with 5 g of LPS from Escherichia coli strain 026:B6 (catalog no. L-2880; SigmaAldrich), 5 g of LPS from E. coli strain 055:B5 (catalog no. L-8274; Sigma-Aldrich), or no LPS. Intranasal deliveries were in 30-l volumes of PBS. E. coli strain 055:B5 LPS induced a more robust neutrophil recruitment to the lungs compared with E. coli strain 026:B6 LPS. Blood and lungs were analyzed 1 day after intranasal delivery.
Transplantation of congenic bone marrow chimera
Seven-to 8-wk-old CD45.1 ϩ congenic C57BL/6 mice were lethally irradiated with two doses of 650 rad 18 h apart. After the second irradiation, C57BL/6 CD45. 
Labeling monocytes with latex particles
Circulating monocytes were labeled with particulates as previously described (22, 28) . In brief, Ly-6C low monocytes were labeled by i.v. injection of 200 l of 0.5-m or 1.0-mm FITC-like plain latex microspheres (Polysciences) diluted to 0.1% (w/v) in PBS without calcium or magnesium. Labeling of Ly-6C high monocytes was achieved by first injecting 200 ml of clodronate-loaded liposomes (32) i.v. 18 h before a subsequent injection of latex beads (28) . Mice were sacrificed at day 1, 2, 4, or 6 after monocyte labeling. In some cases, data were normalized to account for the fact that only a portion of a given monocyte subset carried latex. Normalization calculations were done as previously described (22) . That is, we calculated the frequency of total labeled monocytes of each subset in the circulation. To do this for each animal at each time point available, we multiplied the percentage of blood PBMCs that were Ly-6C high or Ly-6C low monocytes (depending on the subset being traced) by the percentage of latex ϩ monocytes. This value represents the percentage of latex ϩ PBMCs and is a reliable normalization factor because total PBMC counts did not vary significantly in response to any of the experimental manipulations. We then took a mean value of the relevant time points available. We divided the percent labeled pulmonary DCs by this fraction to derive a normalized value for how many DCs would be labeled if all monocytes of a given subset carried latex. Some mice received an i.v. injection of latex beads at the same time that 4 g of pertussis toxin (P7208; Sigma-Aldrich) was injected, and then BAL cells carrying latex were quantified 1 day later.
Flow cytometry and monocyte counts
Blood was collected via tail vein bleeds in heparinized capillary tubes and 20 l was placed into 400 l of Turk's blood diluting fluid for white blood cell counting (catalog no. 8850-16; Ricca Chemical). Total leukocyte counts were then measured using a hemocytometer. The total number of monocyte subsets per milliliter in the blood was calculated by using the percentage of a given monocyte subset, assessed by flow cytometry using the Abs described below, times the total number of leukocytes per milliliter.
Single-cell suspensions were obtained from BAL and whole lung parenchyma. Mice were sacrificed using CO 2 . BAL was obtained by flushing the airways four times with 1 ml of 0.5 mM EDTA/HBSS. After BAL collection, the blood was collected via the heart with a 1-ml syringe containing 10 l of 100 mM EDTA. The blood was resuspended in 7.5 ml of ammonium chloride lysing reagent (BD Biosciences) for 5 min, followed by the addition of 7.5 ml of HBSS containing 0.2% BSA and 2 mM EDTA for 5 min. Then the blood was washed twice in DMEM. Immediately after blood extraction, the lungs were perfused through the heart with a 30-ml syringe containing 0.3 mM EDTA/PBS, which left the lungs free of visible blood. The lungs were then excised, minced, and digested with collagenase D (Roche) for 30 min. Single-cell suspensions were generated by pressing digested whole lung through a 70-m cell strainer. Lastly, all cells were resuspended in FACS blocking solution and stained for 30 min with conjugated Abs from eBioscience or BD Biosciences. The following purified mAbs were used for staining: PE-conjugated mAbs to I-A b , CD11b, CD115, or CD45.2; PerCP-conjugated mAbs to Gr-1 (recognizes Ly-6C and Ly-6G) or CD11b; and allophycocyanin-conjugated mAbs to CD11c, Gr-1 (recognizes Ly-6C and Ly-6G), or CD45.1. CCR2 mAb was previously described (33) . Appropriate isotype-matched control mAbs were also obtained from BD Biosciences.
Polymerase chain reaction
Monocyte subsets were subjected to high-speed flow cytometric sorting to separate CD115 ϩ F4/80 ϩ blood monocytes that were Ly-6C high or Ly-6C low . RNA was isolated with TRIzol reagent according to the manufacturer's instructions (Invitrogen Life Technologies). The purified RNA was subsequently reverse transcribed into cDNA using oligo(dT) [12] [13] [14] [15] [16] [17] [18] primers (Invitrogen Life Technologies). Primers (5Ј to 3Ј sequences) for quantitative real-time PCR analysis were GAPDH sense, GTGGGGCGCCCCAG GCACCA and GAPDH antisense, GTCCTTAATGTCACGCAC GATTTC. Bcl-2 primers were purchased from R&D Systems and used according to their recommendations.
Statistics
Statistical analysis was conducted using InStat and Prism software (GraphPad). All results are expressed as the mean Ϯ SEM. Statistical tests were performed using the one-tailed Student t test. A value of p Ͻ 0.05 was considered statistically significant.
Results
Pulmonary DC subsets and markers of differentiation
In contrast to other organs, CD11c expression in the lung does not distinguish DCs and macrophages. Pulmonary DC and macrophage populations are both CD11c ϩ but can be distinguished by differing levels of surface MHC class II (MHC II) and autofluorescence. DCs have low autofluorescence, whereas macrophages are highly autofluorescent (34, 35) in both the bronchoalveolar space and lung interstitium (Fig. 1A) gfp/ϩ mice (13, 14) . However, we observed that whereas the majority of the CD11b high DCs expressed GFP in CX3CR1 gfp/ϩ and CX3CR1 gfp/gfp mice, none of the CD103 ϩ DCs were GFP ϩ (Fig. 1B) . Thus, tracing GFP from CX3CR1 gfp mice to inclusively identify myeloid DCs in tissues is limited. When examining GFP-negative mouse strains, low autofluorescent CD11c ϩ cells were gated in an open (no staining) FL-1 channel typically used to observe fluorescence associated with FITC (Fig.  1A) . In CX3CR1 gfp mice, low autofluorescent DCs were identified using an open FL-2 channel (typically used to identify R-PE-conjugated Abs) to avoid interference with GFP ϩ cells (Fig. 1B , arrow) that included DCs. Finally, staining with CCR2 mAb in WT and CCR2 KO mice showed the expected reduction in CCR2 staining on Ly-6C low monocytes compared with Ly-6C high monocytes. BAL DC subsets also differentially expressed CCR2, with CD103
ϩ DCs expressing higher levels than CD11b high DCs (Fig. 1C) .
Tracing the fate of labeled monocyte subsets in the lung and BAL
To study the fate of monocyte subsets in the lung, we first used methods to label monocytes endogenously with 0.5-m latex beads introduced i.v. Depending on the conditions of labeling, Ly-6C high or Ly-6C low monocytes are selectively labeled, and each population remains in the circulation for several days as they gradually decline in number within the blood (22, 28, 36) . Within ϳ1 wk after Ly-6C high monocytes are labeled, the fraction remaining in blood converts to Ly-6C low monocytes (28) . These methods do not affect the migration patterns of labeled monocytes and do not induce inflammatory cytokines that can be detected in serum (22) . Indeed, results obtained with these methods are in complete agreement with adoptive transfer approaches in different models (22, 23, 36, 37) and have the capacity to sensitively trace endogenous monocytes.
Two cohorts of mice were independently treated to label Ly-6C low or Ly-6C high monocyte subsets, and the migration and differentiation of each subset in lung and BAL were traced. To analyze the contribution of monocytes giving rise to DCs in the lung and BAL, total DCs were first gated ( Fig. 2A, left plots) and then latex ϩ DCs were examined ( Fig. 2A ). Approximately 80% of the recovered latex ϩ DCs that originated from Ly-6C low monocytes were CD11b high DCs, whereas the labeled Ly-6C high monocytes gave rise to both DC subsets at relatively equal frequency during all time points (Fig. 2, A and B) . This outcome matches the staining pattern for CCR2, since the monocyte subset with the highest CCR2 expression was the only population of monocytes that was linked to the CD103 ϩ DCs, which likewise express higher CCR2 than their CD11b high counterparts (Fig. 1C) .
Acquisition of latex by pulmonary DCs was inhibited by pertussis toxin treatment of the mice (Fig. 2C) , consistent with a role for latex ϩ migratory cells as their precursors rather than passive transfer of the latex to DCs. Within the total DCs, CD11b high DCs were often reduced in frequency following the clodronate-liposome treatment used in the Ly-6C high monocyte-labeling protocol ( Fig. 2A , see histograms of total DCs), although treatment with the clodronate-loaded liposomes had no statistically significant impact on the total numbers of pulmonary DCs (data not shown). This finding fits well with our knowledge that Ly-6C high monocytes return to the blood much sooner than Ly-6C low monocytes after clodronate treatment (16, 28) and is independently consistent with pulmonary CD11b high DCs arising from Ly-6C low blood monocytes, as suggested from the latex tracing method.
To estimate the extent to which blood monocyte subsets replaced lung or BAL DCs, we normalized to account for the fraction of each subset of monocyte that was labeled. The normalized data estimate the upper limit in the fraction of total DCs that would be labeled if all monocytes of a given subset had carried latex. Because the latex-labeling method may have some so far unrecognized impact on monocyte trafficking, we emphasize that these data are merely an estimate. Nonetheless, the data suggest that, collectively, the two monocyte subsets could account for the generation of the majority of interstitial DCs by day 4 after labeling ( Fig. 2D) . A major difference between the subsets, however, is that DCs generated from Ly-6C high monocytes account for most of the CD103 ϩ DCs (Fig. 2D , compare height of black bars). Ly-6C low and Ly-6C high monocytes appeared to contribute similarly to CD11b high DCs (Fig. 2D) , closely resembling the outcome after monocyte adoptive transfer of Ly-6C high monocytes (14) . By comparison to interstitial lung DCs, BAL DCs were more slowly and less efficiently labeled and, even after normalization, only ϳ20% of total DCs were replaced collectively by the two monocyte subsets within 6 days (Fig. 2D) . Labeled DCs in the BAL were first evident at day 2, peaked at day 4, and decreased by day 6. By day 35, no latex ϩ DCs were found in BAL (data not shown), indicating that the label does not persist in the BAL indefinitely. Just as for interstitial DCs, essentially all latex-labeled CD103
ϩ DCs in BAL arose only from the Ly-6C high monocyte subset (Fig. 2D ), but both labeled monocytes subsets became CD103 Ϫ CD11b high DCs. 
Monocyte subsets and pulmonary DC subsets in parabiotic mice show matched frequency of mixing between parabionts
Considering this evidence along with the finding that adoptively transferred monocytes could, at minimum, differentiate into CD11b high DCs (14), we closely examined monocyte subsets in parabiotic mice and specifically compared the degree of mixing between the parabiotic partner genotypes within each blood monocyte subset to the degree of mixing of partner genotypes in pulmonary DC populations. Similar to Liu et al. (38) , we observed that Ly-6C high monocytes (called inflammatory monocytes by Liu et al. (38) ) were not fully mixed between the partners, possibly because the Ly-6C high monocytes emigrate from bone marrow and clear from the bloodstream more rapidly than they were able to mix between partners (38) (Fig. 3A) . In these same parabiotic partners, however, blood Ly-6C low monocytes were more evenly mixed between the partners (Fig. 3A) , in agreement with Liu et al. (38) who called these cells "stationary monocytes." Blood Ly-6C low monocytes arise with a few days delay from Ly-6C high monocytes (13, 16, 28) ; therefore, these monocytes likely had circulated to the other partner before or during their conversion from Ly-6C high monocytes. Pulmonary CD103 ϩ DCs showed a very similar degree of mixing between partner genotypes as Ly-6C high monocytes, whereas CD11b high DCs showed the same degree of mixing as observed in Ly-6C low monocytes (Fig. 3A) . These data, therefore, lead to a similar indication as the latex bead tracking approach above, suggesting that Ly-6C low monocytes preferentially give rise to CD11b high DCs and that CD103 ϩ pulmonary DCs primarily derive from Ly-6C high monocytes. Next, in individual mice, a correlation with the fraction of Ly-6C low monocytes and the fraction of CD11b high pulmonary DCs was observed in response to LPS challenge. Introduction of LPS into the airway led to a doubling in the number of DCs in the BAL 24 h later (data not shown), a condition in which new DCs are rapidly recruited. LPS treatment intranasally also shifted monocyte toward the Ly-6C low subset (Fig. 3B) . We observed a close correlation between the fraction of Ly-6C low monocytes and the fraction of CD11b high pulmonary DCs in lung and BAL using two types of LPS (Fig. 3B) . These data fit well with the possibility that newly recruited monocytes during inflammation may differentiate into pulmonary DC subsets that reflect the frequency of monocyte subsets in the blood. In particular, there was a strong relationship between the percentage of Ly-6C low monocytes in blood and the percentage of BAL or lung DCs (Fig. 3B) 
Analysis of CCR2 and CX3CR1 pathways in mice reconstituted with mixed bone marrow cells
To further test the respective roles of monocyte subsets in serving as precursors of pulmonary DCs, we analyzed how pulmonary DC subsets were affected by perturbations in the major chemokine receptor pathways that characterize the monocyte subsets. Ly-6C high monocytes express CCR2 (15, 24) and use it to exit the bone marrow and enter blood (27) 
precursors than CCR2
Ϫ/Ϫ precursors in chimeric mice bearing mixed bone marrow cells from WT and CCR2 Ϫ/Ϫ mice. Ly-6C low monocytes express lower levels of CCR2 than Ly-6C high monocytes (25) (Fig. 1C ), but they express high levels of CX3CR1 (15) . We observed that CD11b high pulmonary DCs were markedly and selectively reduced in naive CX3CR1-deficient mice (CX3CR1 gfp/gfp ; Fig. 4A ). That is, the total number of pulmonary DCs was not altered in these strains, but the fraction of CD11b high DCs was significantly reduced compared with their WT counterparts (Fig. 4A) Analysis of the blood of mice that received a mixture of WT and CX3CR1-deficient cells revealed a selective deficiency in the number of Ly-6C low monocytes that derived from CX3CR1-deficient cells, compared with their WT CD45.2 ϩ counterparts (Fig. 4B ). Ly-6C low CX3CR1-deficient monocytes were not elevated in the bone marrow compared with WT monocytes in the same animals, since the fraction of CX3CR1-deficient monocytes (CD45.2 ϩ ) that were Ly-6C low was below the fraction of WT (CD45.2 Ϫ CD45.1 ϩ )
Ly-6C low monocytes (Fig. 4C) . Thus, CX3CR1 is apparently not required for Ly-6C low monocytes to exit the bone marrow, as is the case for Ly-6C high monocytes in CCR2-deficient mice (27) , but instead this chemokine receptor is apparently involved in a more downstream step that involves the conversion of Ly6C high monocytes into Ly6C low monocytes or survival of these monocytes. When we examined expression of the classic antiapoptotic gene bcl-2 in Ly-6C low monocytes, we observed that bcl-2 mRNA was very low in CX3CR1 gfp/gfp compared with WT Ly-6C low monocytes (Fig. 4D) , suggesting the possibility that Ly6C low CX3CR1-deficient monocytes may be more susceptible to death by apoptosis than their WT counterparts.
To analyze how the lack of chemokine receptors affected repopulation of pulmonary DCs, we reasoned that if both of the genotypes in the mixed bone marrow chimeras were equally efficient in generating CD103
ϩ CD11b low and CD11b high pulmonary DC subsets, the ratio of the pulmonary DC subsets relative to each other should be close to a value of 1.0 when the two genotypes were compared. The total number of DCs was not significantly different between the various chimeric animals (data not shown). Thus, we determined the relative frequency of CD11b high DCs to CD11b low DCs in each animal for both genotypes in the chimera and then made a ratio of those two values (Fig. 4E) . We separately analyzed DCs in the BAL and the lung interstitium. Indeed, when data from all mice were compiled, these ratios hovered near 1.0 in the WT mixed chimeras (Fig. 4F) . However, CCR2-deficient cells were less able to repopulate CD103 ϩ CD11b low DCs relative to CD11b high DCs, shifting the ratio toward a value of 2.0 (Fig. 4F ), indicative of a requirement for CCR2 in optimal reconstitution of CD103 ϩ CD11b low DCs. Conversely, CX3CR1-deficient cells were less able to repopulate CD11b high DCs, shifting the ratio significantly below 1.0 (Fig. 4F) , illustrating a critical role for low and Ly-6C high monocyte shifts in the blood 1 day after LPS treatments. These data show results of one experiment (n ϭ 3 per experimental cohort) that are representative of a total of three experiments conducted. 
CX3CR1
gfp/gfp bone marrow cells. CD115 ϩ monocytes were gated before the generation of these plots to reveal the frequency of Ly-6C high and Ly-6C low monocytes that were from WT (CD45.2 Ϫ CD45.1 ϩ ) or CX3CR1-deficient (CD45.2 ϩ ) mice. D, Bcl-2 expression was analyzed by quantitative real-time PCR in sorted Ly-6C low monocytes. Data are representative of two independent sorts and analyses. E, Analysis of pulmonary DC subsets in mice with chimeric, mixed bone marrow. One representative analysis in BAL and lung is shown for all chimeric animals. Cells were gated on total DCs. We determined the relative frequency of CD11b high DCs to CD11b low DCs (CD11b high DC/CD11b low DC) in each animal for both genotypes in the chimera (italicized numbers to the right of the dot plots) and then made a ratio of those two genotype values (CD45.1/CD45.2, ratio shown as bolded numeral near the lower right quadrant of each dot plot). We separately analyzed DCs in the BAL (upper panels) and the lung interstitium (lower panels). F, Scatter plot graph shows analyzed pulmonary DC subsets for all individual chimeric mice studied. Differences between WT:WT and WT:CCR2 Ϫ/Ϫ or WT:CX3CR1 Ϫ/Ϫ cohorts are significantly different, p Ͻ 0.001. Throughout this figure, CCR2 refers to CCR2 Ϫ/Ϫ cells and CX3CR1 to CX3CR1-deficient cells.
CX3CR1 in reconstituting CD11b
high DCs. Fig. 4F shows data for BAL DCs and very similar results were observed for interstitial DCs. Thus, the failure of CCR2-and CX3CR1-deficient cells to allow normal numbers of Ly-6C high and Ly-6C low monocytes to circulate, respectively, correlates with a failure of CCR2-and CX3CR1-deficient cells to populate CD103 
Discussion
Previous studies on the role of monocytes as DC precursors had led to the emergence of a view that monocytes may only convert to DCs during inflammation (39) . In the steady state, monocytes do not contribute to the DC populations in spleen (13, 40, 41) , but following infection or sterile inflammation, they become a specialized type of splenic DCs and/or develop into DCs in other inflamed organs (15, 17, 21, 41, 42) . However, recent data indicate that after DCs are artificially ablated in the airway and lung, adoptively transferred monocytes can contribute to their repopulation (13) , and further work revealed that monocytes became pulmonary DCs in resting mice even in the absence of ablation or overt inflammation (14) . These studies raised the possibility that DCs in peripheral organs, including but not limited to lung, may arise at least to some extent from monocytes in the steady state. A major limitation of these studies is that by tracing GFP ϩ DCs in CX3CR1 gfp/ϩ mice. Our approach permitted analyses of both conventional pulmonary DC subpopulations. We confirm a role for monocytes as precursors of pulmonary DCs in the absence of inflammation and we reveal for the first time that both monocyte subsets differentiate differently after recruitment into lung, respectively, developing into distinct subsets of conventional DCs in the airway and lung interstitium. We took four different experimental approaches in this work. One particularly powerful method for assessing the potential validity of relationships of monocyte subsets with particular populations of DCs or macrophages, providing that they are rapidly turned over by blood precursors, is parabiosis, since monocyte subsets are not shared equally between parabiotic partners (Ref. 38) and Fig. 3) . DCs in the lung turnover rapidly, and we found that the extent to which these DCs have mixed between parabiotic partners relates to the extent of mixing that occurred in blood monocytes. That is, the mixing of genotypes between parabionts from Ly-6C high monocytes is similar to the mixing observed in CD103 ϩ pulmonary DCs. A different degree of mixing occurred for CD11b high DCs and this matched circulating Ly-6C low monocytes closely. Results from this and all other methods we used converged on the conclusion that Ly-6C low monocytes appear to be precursors of CD11b high DCs and do not contribute to CD103 ϩ DCs. By contrast, all methods indicated that Ly-6C high monocytes were selectively able to generate CD103 ϩ DCs. The fact that so many distinct approaches, each with differing underlying principles and each with different pros and cons, converge on similar outcomes strongly suggest that CD11b high DCs are mainly repopulated by Ly-6C low monocytes, whereas CD103 ϩ DCs selectively derive from Ly-6C high monocytes. Indeed, we strongly advocate a multipronged approach to tracing monocytes, because each approach adds power to evaluation of the hypothesis. To illustrate, one might argue that a small number of cells other than, for instance, Ly-6C low monocytes took up latex beads in the circulation and became pulmonary DCs rather than the Ly-6C low monocytes. If that were true, then to fit with data from the other approaches the "mystery precursor" would not only have had to acquire latex beads in a similar manner as these monocytes, but they would have to have the same degree of mixing between parabiotic partners as the monocytes, the same profile as Ly-6C low monocytes in responding to intranasal LPS, and the same responses to the absence of CX3CR1 as Ly-6C low monocytes when we generated mixed chimeric mice. The probability that all of these characteristics would closely overlap in two unrelated cells is very low. Indeed, this probability would likely be much lower than the probability that the contaminating cells in monocyte adoptive transfer experiments, rather than the monocytes, are the real precursors for DCs observed in tissues after transfer. Only ϳ2% of adoptively transferred cells can be recovered after transfer (15) , increasing the chances that robust or proliferative contaminants could account for the source of progeny in adoptive transfer-based fate mapping. Finally, we also see an advantage of coupling parabiotic and chimerism studies with manipulative techniques that involve labeling or adoptive transfer of monocytes, because when all approaches agree, it is difficult to argue that the findings are simply an artifact of manipulation.
Similar to adoptive transfer experiments (14) CCR2 is critical in monocyte homeostasis, at least in part because this chemokine receptor is needed for Ly-6C high monocytes to egress from the bone marrow (27) . Consequently, CCR2 Ϫ/Ϫ mice have dramatically reduced blood Ly-6C high monocytes (21, 27) , but normal Ly-6C low monocytes (21) . Ly-6C low monocytes are CCR2 negative but express high levels of CX3CR1. A role for CX3CR1 in the homeostasis of Ly-6C low monocytes has not been previously appreciated. When we quantified Ly-6C low monocytes in mixed bone marrow chimeras wherein WT and CX3CR1-deficient hemopoietic cells were present in the same host, there was a marked reduction of Ly-6C low CX3CR1 Ϫ/Ϫ monocytes compared with WT monocytes in the same animal. In contrast to the role for CCR2 in driving emigration of Ly-6C high monocytes from the bone marrow, this defect in Ly-6C low monocytes could not be attributed to failure of Ly-6C low monocytes to emigrate from the bone marrow. Instead, we found that CX3CR1 was needed to maintain bcl-2 expression in Ly-6C low monocytes, raising the possibility that CX3CR1 regulates their survival at least in some conditions through expression of survival genes such as bcl-2. A role for CX3CR1 in survival might have been anticipated from previous studies wherein a 1:1 mixture of CX3CR1 gfp/ϩ and CX3CR1 gfp/gfp Ly-6C low monocytes was transferred into WT hosts revealed a 80% relative loss of CX3CR1 gfp/gfp monocytes compared with CX3CR1 gfp/ϩ monocytes not only in lung but also in blood (15) , suggesting that survival of CX3CR1 gfp/gfp in the circulation was reduced. However, those data were instead interpreted to indicate a role for CX3CR1 in monocyte migration. Other studies reported generally fewer F4/80 ϩ blood cells in the absence of CX3CL1, consistent with a need for CX3CL1 and CX3CR1 for survival of some monocytes (43) . These findings raise the need to consider a role for CX3CR1 in monocyte survival and not solely as a mediator of trafficking. A role for CX3CR1 in Ly-6C low monocyte survival could directly lead to the observed decrease in CD11b high DCs in the lung, but there may also be direct roles for CX3CR1 in maintaining survival in other locations, including the lung itself.
Because CCR2 ϩ monocytes respond robustly to inflammation, Ly-6C high CCR2 ϩ monocytes in the mouse are often called "inflammatory monocytes." This term should be used carefully to avoid the implication that these monocytes may preferentially develop into effectors of inflammation. Instead, our data indicate that in lung they are selectively prone to give rise to CD103 ϩ DCs.
Inasmuch as CD103
ϩ DCs can be linked to events in the negative regulation of immune responses (3, 4) , these monocytes do not seem to necessarily generate inflammation-promoting differentiation products. CCR2 ϩ monocytes are also linked to the replenishment of skin Langerhans cells in severe injury (36) , and Langerhans cells, likewise, appear to function in many instances as negative regulators of immune responses (44) . Furthermore, the cells referred to as Gr-1 ϩ myeloid suppressor cells that become highly elevated in tumor-bearing mice possess a phenotype that is closely overlapping with, and possibly identical to, Ly-6C high monocytes (45) . Thus, there may be multiple instances wherein Ly-6C high monocytes give rise to differentiated APCs that work to curtail immune reactivity. Finally, it is known that depletion of Gr-1 ϩ cells in mouse models of asthma destroys the normal underlying mechanisms in negative immune regulation and promotes airway inflammation (46) . Whereas this outcome can be at least partly explained by the depletion of plasmacytoid DCs in the lung with anti-Gr-1 Ab, it is also possible that the depletion of Ly-6C high (Gr-1 ϩ ) monocytes contributed to the loss of negative regulation. It is obvious that a more detailed analysis of the functional roles of CD103 ϩ and CD11b high DCs is needed, although recent progress has been made (4, 5). Because we reveal that these DC populations in lung are differentially replenished by distinct monocyte subsets that, respectively, use distinct chemokine receptor pathways, approaches to alter the composition of pulmonary DC subpopulations for the possible modulation of pulmonary immune responses and inflammation becomes evident.
